| Product Code: ETC9519594 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import shipments of pneumococcal polysaccharide vaccine in 2024 were predominantly sourced from the United States of America, Trinidad and Tobago, Brazil, and the Netherlands. The market concentration, as indicated by the Herfindahl-Hirschman Index (HHI), remained significantly high in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was robust at 23.24%, with an impressive growth rate of 81.21% from 2023 to 2024. These statistics demonstrate a strong demand for pneumococcal polysaccharide vaccine in Suriname, with key exporters driving the market growth.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Pneumococcal Polysaccharide Vaccine Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Pneumococcal Polysaccharide Vaccine Market - Industry Life Cycle |
3.4 Suriname Pneumococcal Polysaccharide Vaccine Market - Porter's Five Forces |
3.5 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume Share, By Dosage, 2022 & 2032F |
3.6 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Suriname Pneumococcal Polysaccharide Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Suriname |
4.2.2 Government initiatives to improve healthcare infrastructure and vaccination programs |
4.2.3 Rising prevalence of pneumococcal diseases in Suriname |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Suriname |
4.3.2 High cost associated with pneumococcal polysaccharide vaccines |
4.3.3 Lack of healthcare professionals trained in administering vaccines effectively |
5 Suriname Pneumococcal Polysaccharide Vaccine Market Trends |
6 Suriname Pneumococcal Polysaccharide Vaccine Market, By Types |
6.1 Suriname Pneumococcal Polysaccharide Vaccine Market, By Dosage |
6.1.1 Overview and Analysis |
6.1.2 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Dosage, 2022 - 2032F |
6.1.3 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Single Dose Vial, 2022 - 2032F |
6.1.4 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Pre-Filled Syringe, 2022 - 2032F |
6.2 Suriname Pneumococcal Polysaccharide Vaccine Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Children (2-10 Age), 2022 - 2032F |
6.2.3 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Adult (10-64 Age), 2022 - 2032F |
6.2.4 Suriname Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Geriatric (More Than 65 Age), 2022 - 2032F |
7 Suriname Pneumococcal Polysaccharide Vaccine Market Import-Export Trade Statistics |
7.1 Suriname Pneumococcal Polysaccharide Vaccine Market Export to Major Countries |
7.2 Suriname Pneumococcal Polysaccharide Vaccine Market Imports from Major Countries |
8 Suriname Pneumococcal Polysaccharide Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate in Suriname |
8.2 Number of public health campaigns promoting pneumococcal polysaccharide vaccines |
8.3 Percentage of children and elderly population vaccinated against pneumococcal diseases |
9 Suriname Pneumococcal Polysaccharide Vaccine Market - Opportunity Assessment |
9.1 Suriname Pneumococcal Polysaccharide Vaccine Market Opportunity Assessment, By Dosage, 2022 & 2032F |
9.2 Suriname Pneumococcal Polysaccharide Vaccine Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Suriname Pneumococcal Polysaccharide Vaccine Market - Competitive Landscape |
10.1 Suriname Pneumococcal Polysaccharide Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Suriname Pneumococcal Polysaccharide Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here